RAPPAPORT ANDREW
SEC insider (Form 3/4/5 filer). CIK 0001162157. Director at Olema Pharmaceuticals, Inc. (OLMA). 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2026. Located in SAN FRANCISCO, CA.
Companies RAPPAPORT ANDREW has filed insider reports for
- Olema Pharmaceuticals, Inc. (OLMA): Director
RAPPAPORT ANDREW
CIK: 0001162157
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)1 (25.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (25.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
OLMA
Olema Pharmaceuticals, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 18, 2026OLMA
Olema Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
29.5K shares- - Nov 25, 2025OLMA
Olema Pharmaceuticals, Inc.
GiftDirect35.9K shares- - Nov 21, 2025OLMA
Olema Pharmaceuticals, Inc.
ExerciseDirect35.9K shares at avg. $0.39$14K - Jun 11, 2025OLMA
Olema Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
24.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 | OLMA Olema Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 29,500 | - | - | Direct |
| Nov 25, 2025 | OLMA Olema Pharmaceuticals, Inc. | Gift | 35,868 | - | - | Direct |
| Nov 21, 2025 | OLMA Olema Pharmaceuticals, Inc. | Exercise | 35,868 | $0.39 | $13,989 | Direct |
| Jun 11, 2025 | OLMA Olema Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 24,150 | - | - | Direct |
1-4 of 4 transactions